ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to slash leukemia relapse after bone marrow transplant
Disease control Recruiting nowThis study tests whether adding two drugs (ruxolitinib and decitabine) to the standard chemotherapy given before a stem cell transplant can lower the chance of leukemia returning in high-risk patients. About 200 adults and teens with acute myeloid leukemia in first remission will…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Massive study aims to beat deadly fungal infections in transplant patients
Knowledge-focused Recruiting nowThis study tracks 6,000 people who had a stem cell transplant to learn more about serious fungal infections that can occur afterward. Researchers will collect information on diagnosis, treatment, and outcomes over five years. The goal is to find better ways to prevent and treat t…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 02:38 UTC
-
New study aims to catch lung damage early in transplant patients
Knowledge-focused Recruiting nowThis study looks for better ways to find lung inflammation early in people who have received a stem cell transplant from a donor. Researchers will use special CT scans, lung washes, blood tests, and breathing tests before and for two years after the transplant. The goal is to see…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
New study aims to personalize chemo dosing for blood cancer patients
Knowledge-focused Recruiting nowThis study looks at how kidney function and race/ethnicity affect the way the drug treosulfan works in people with acute myeloid leukemia or myelodysplastic syndrome who are getting a stem cell transplant. The goal is to find the safest dose for those with kidney problems. About …
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: PHASE1 • Sponsor: medac GmbH • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC